A new Finnish study from the University of Turku shows that a 30-minute exercise session can increase the proportion of tumor-killing white blood cells in the bloodstream of breast cancer patients.
Jul 3, 2024
0
3
Researchers at Weill Cornell Medicine with an international team have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic cancer will spread to ...
Jun 28, 2024
0
28
Periods of fasting reprogram the immune system's natural killer cells to better fight cancer, according to a new study in mice from researchers at Memorial Sloan Kettering Cancer Center (MSK).
Jun 14, 2024
1
131
Treatment options for those suffering from endometriosis are currently few, but research at Umeå University provides new opportunities to understand the disease. A new thesis answers the question of how cells, which are ...
Jun 5, 2024
0
0
Surgical teams at NYU Langone Health performed the world's first genetically modified pig kidney transplant into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022. These ...
May 21, 2024
0
57
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.
May 21, 2024
0
3
A new study has revealed important insights into how SARS-CoV-2 and its variants escape the immune system. The findings pave the way for new therapeutic approaches against COVID-19.
May 15, 2024
0
28
A new study, led by Jesmond Dalli, professor of molecular pharmacology at Queen Mary University of London, has found that people with a genetic mutation that leads to a reduction in a protein called LGR6, found on the surface ...
May 9, 2024
0
0
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional ...
Apr 22, 2024
0
29
A molecule has demonstrated its ability to kill tumor cells and incite an immune response in preclinical models of small cell lung cancer (SCLC), according to UT Southwestern Medical Center researchers. The findings, published ...
Mar 12, 2024
0
22
